What GLOBAL PLASMA SUPPLY LTD does

Global Plasma Supply Ltd (GPS) is a London-headquartered B2B firm that operates as an intermediary and consultancy in the global plasma-derived medicinal products (PDMP) supply chain. The company serves governments, public healthcare systems, and fractionators in regions — explicitly the East, Middle East, Africa, and the West — that lack developed PDMP pharmaceutical sectors or modern transfusion healthcare infrastructure. Its stated customer base is concentrated among national and regional government buyers and international fractionators seeking distribution into underserved markets.

GPS delivers five integrated service lines: establishment and modernization of plasma collection centers, expert training in plasmapheresis processes, tailored healthcare consultancy, plasma donation awareness programs, and end-to-end PDMP supply chain solutions connecting fractionators, suppliers, and governments to patients. There is no proprietary technology platform disclosed; the offering is services-led rather than software-led. Operations are aligned with AABB, ISBT, FDA, EDQM guidelines, and cGMP standards.

The revenue model combines professional services fees (for consultancy and training engagements) with supply chain facilitation economics (margins or transaction fees on PDMP flows), with quote-based, contract-negotiated pricing typical of enterprise healthcare procurement. Go-to-market is enterprise field sales via direct relationships with governments, healthcare ministries, fractionators, and international societies; the company lists LinkedIn (via the CEO) and direct website inquiry as its primary channels. The firm is founder-led, privately held, with no disclosed external investors, no funding rounds, and headcount of 1-10.

Name

GLOBAL PLASMA SUPPLY LTD

Legal name

Global Plasma Supply Ltd

Website

https://globalplasmasupply.co.uk

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

1–10 employees

Short description

Global Plasma Supply Ltd is a London-based B2B consultancy and supply chain intermediary that helps governments, healthcare systems, and fractionators establish plasma collection centers, train staff, and access plasma-derived medicines in underserved regions across the East, Middle East, Africa, and the West.

Ownership category

akta.pro rank

Product category

Plasma-Derived Medicine Supply Chain Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (4242)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Plasma Collection & Donor Services (Plasmapheresis Centers) (HLAIAHAH)

akta.pro secondary industries

Plasma-Derived & Blood Products Distributors (HLAIAJAJ), Global Health Supply Chain & Procurement Organizations (HLAJAKAL), Health Supply Chain, Procurement & Access to Medicines (BPADAIAI)

Keywords

• Plasma supply chain
• Transfusion medicine
• Plasmapheresis training
• Healthcare consultancy
• Plasma collection centers

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Plasma Collection Center Services: GPS provides consultancy services to establish, improve, and modernize plasma collection centers, including expert training on plasmapheresis processes and operational optimization. Revenue likely derives from service fees for these consultancy and training engagements.
2. Plasma-Derived Medicinal Products Supply: The company facilitates the supply chain for Plasma Derived Medicinal Products (PDMPs), connecting fractionators with healthcare systems in underserved regions. Revenue streams may include product margins and supply chain facilitation fees.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Global Plasma Supply optimizes plasma-derived medicinal product (PDMP) supply chains by establishing, improving, and modernizing plasma collection centers; delivering expert plasmapheresis training; providing healthcare consultancy; and running plasma donation awareness programs. The company connects international fractionators, suppliers, governments, and healthcare systems to deliver life-saving plasma-derived therapies to underserved regions across East, Middle East, Africa, and the West.

Product overview

Global Plasma Supply operates as a unified platform offering integrated services across the plasma-derived medicinal products (PDMPs) supply chain. The company provides a comprehensive portfolio comprising plasma collection center establishment and modernization, plasmapheresis training, healthcare consultancy, and awareness programs. These offerings work together to streamline the journey from donor to patient, bridging healthcare gaps in underserved regions. The core value proposition centers on connecting international fractionators, suppliers, governments, and societies to ensure uninterrupted access to life-saving plasma-derived therapies.

Differentiator

Problem solved

Functional benefit

Products and services

• Plasma Collection Center Establishment & Modernization Services
• Plasmapheresis Training Services
• Healthcare Consultancy Services
• Plasma Donation Awareness Programs
• Global PDMP Supply Chain Solutions

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Four partnerships are on record, tiered core.

• International Societies (unspecified)coreStrategic or Co-development PartnerGPS partners with international societies in the transfusion and plasma industry to drive innovation and improve global healthcare outcomes. These partnerships support the company's mission to enhance accessibility to plasma-derived medicines.
• Fractionators (unspecified)coreChannel Partner/ Reseller/ DistributorGPS collaborates with plasma fractionators to facilitate the supply of Plasma Derived Medicinal Products (PDMPs) to underserved regions. These partnerships are central to the company's distribution strategy.
• Suppliers (unspecified)coreChannel Partner/ Reseller/ DistributorGPS works with plasma suppliers as part of its integrated supply chain approach, ensuring efficient delivery of plasma products from collection centers to patients.
• Governments (unspecified)coreStrategic or Co-development PartnerGPS collaborates with governments to establish plasma collection infrastructure and improve transfusion healthcare in countries lacking developed PDMP pharmaceutical sectors or transfusion healthcare systems.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Octapharma: Swiss-headquartered global manufacturer of plasma-derived therapies with own plasma collection centers. Comparable as a fractionator/supplier with international market access focus that overlaps with GPS's emerging-market distribution positioning.
• Biotest AG: German plasma collection and PDMP manufacturer now part of Grifols. Comparable as a fractionator with plasma collection operations that GPS could partner with or whose supply chain GPS could complement in underserved regions.
• Kedrion Biopharma: Italy-based plasma fractionator producing PDMPs with a global commercial network. Comparable as a mid-sized fractionator focused on international and emerging-market PDMP access, similar profile to GPS's targeted regions.
• Sanquin Blood Supply Foundation: Dutch nonprofit blood bank and plasma fractionator. Comparable as a national blood/plasma collector with international consultancy role, similar in structure to GPS's collection-center establishment and supply chain services.
• Bio Products Laboratory (BPL): UK-headquartered plasma fractionator producing PDMPs (immunoglobulins, albumin, clotting factors) for global markets. Comparable to GPS as a UK-based PDMP player; BPL operates the fractionation side while GPS facilitates access and collection-center buildout in underserved regions.
• LFB (Laboratoire Français du Fractionnement et des Biotechnologies): French plasma fractionator producing PDMPs for French and international markets. Comparable as a European fractionator that GPS could source from for emerging-market supply contracts.

Broad incumbents

• CSL Behring: One of the largest global plasma-derived therapy manufacturers and plasma collectors, part of CSL Limited. Comparable as a major fractionator and PDMP supplier that GPS could route products from into underserved regions.
• Grifols: Global plasma collection and fractionation leader with vertically integrated centers and PDMP manufacturing. Comparable as the dominant incumbent whose supply GPS facilitates to emerging markets; Grifols also operates donation centers that GPS could partner with or compete against.
• Takeda Pharmaceutical Company (Plasma-Derived Therapies): Global pharmaceutical company with a major plasma-derived therapy franchise acquired from Shire. Comparable as a large fractionator of immunoglobulins and other PDMPs with presence in emerging markets that GPS targets.

Regional players

• GC Biopharma (formerly Green Cross Corporation): Korean plasma-derived therapy manufacturer with international distribution. Comparable as a regional fractionator with focus on expanding into Middle East and African markets where GPS operates.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/in/antoine-francis-gps

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GLOBAL PLASMA SUPPLY LTD